Subsequently, GAD65 antibodies were also identified in patients with autoimmune cerebellar ataxia (ACA), limbic encephalitis (LE) and epilepsy (Ep).The complexity of the disease is influenced by diverse clinical phenomena and different prognoses. The gene discussed is GAD2; the disease is epilepsy.